Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 1 open-market purchase and 8 sales; 571 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:11 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $144.3M (3.6% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 25, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Feb 19, 2025 | Feb 14, 2024 | Feb 22, 2023 | Feb 16, 2022 |
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B |
| Selling, general and administrative | $743.1M | $751.0M | $747.9M | $665.1M | $619.9M |
| Operating income | $25.2M | $227.3M | $617.3M | $651.0M | $589.9M |
| Interest expense | – | – | $136.7M | $59.3M | $73.9M |
| Income tax | $42.7M | $67.8M | $100.9M | $130.4M | $81.9M |
| Net income | -$144.3M | $22.2M | $474.6M | $486.2M | $391.0M |
| EPS, basic | $-2.91 | $0.20 | $9.27 | $9.57 | $7.77 |
| EPS, diluted | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 |
| Weighted shares, basic | 49.6M | 51.4M | 51.2M | 50.8M | 50.3M |
| Weighted shares, diluted | 49.6M | 51.6M | 51.5M | 51.3M | 51.4M |
| Margins and growth | |||||
| Operating margin | 0.6% | 5.6% | 14.9% | 16.4% | 16.7% |
| Net margin | -3.6% | 0.5% | 11.5% | 12.2% | 11.0% |
| Revenue growth, year over year | −0.9% | −1.9% | +3.9% | +12.3% | +21.1% |
| Net income growth, year over year | −750.1% | −95.3% | −2.4% | +24.4% | +7.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 25, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Feb 19, 2025 | Feb 14, 2024 | Feb 22, 2023 | Feb 16, 2022 |
| Cash and equivalents | $213.8M | $194.6M | $276.8M | $233.9M | $241.2M |
| Short-term investments | – | – | – | – | $1.06M |
| Accounts receivable | $708.9M | $720.9M | $780.4M | $752.4M | $642.9M |
| Inventory | $299.1M | $278.5M | $380.3M | $255.8M | $199.1M |
| Total current assets | $1.45B | $1.40B | $1.61B | $1.44B | $1.27B |
| Property, plant and equipment | $1.66B | $1.60B | $1.64B | $1.47B | $1.29B |
| Goodwill | $2.76B | $2.85B | $3.10B | $2.85B | $2.71B |
| Intangible assets | $340.0M | $723.4M | $864.1M | $955.3M | $1.06B |
| Total assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B |
| Accounts payable | $148.8M | $140.3M | $168.9M | $205.9M | $198.1M |
| Short-term debt | $166.0K | $155.0K | $3.17M | $1.35M | $101.0K |
| Total current liabilities | $1.12B | $994.1M | $1.06B | $1.09B | $1.03B |
| Total liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B |
| Shareholders' equity | $3.17B | $3.47B | $3.60B | $2.98B | $2.54B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 25, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Feb 19, 2025 | Feb 14, 2024 | Feb 22, 2023 | Feb 16, 2022 |
| Operating cash flow | $737.6M | $734.6M | $683.9M | $619.6M | $760.8M |
| Capital expenditures | $219.2M | $233.0M | $318.5M | $324.7M | $228.8M |
| Free cash flow | $518.5M | $501.6M | $365.4M | $294.9M | $532.0M |
| Depreciation and amortization | $403.3M | $361.7M | $314.1M | $303.9M | $265.5M |
| Stock-based compensation | $71.1M | $69.9M | $72.0M | $73.6M | $71.5M |
| Share buybacks | $360.7M | $119.2M | $24.2M | $38.7M | $40.7M |
| Investing cash flow | -$209.3M | -$245.1M | -$563.2M | -$607.9M | -$1.44B |
| Financing cash flow | -$536.7M | -$550.9M | -$85.5M | -$42.4M | $672.6M |
| Net change in cash | $10.4M | -$78.9M | $43.3M | -$5.10M | $13.2M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.8% | 1.7% | 1.7% | 1.9% | 2.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 24, 2026 | 47.9M | −2.6% | SEC |
| Jul 25, 2026 | 47.7M | −3.0% | SEC |
| Apr 24, 2026 | 48.2M | −1.9% | SEC |
| Jan 24, 2026 | 49.2M | −3.7% | SEC |
| Oct 25, 2025 | 49.2M | −3.8% | SEC |
| Jul 26, 2025 | 49.2M | −4.7% | SEC |
| Apr 26, 2025 | 49.1M | −4.7% | SEC |
| Jan 25, 2025 | 51.1M | −0.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.